Literature DB >> 22380708

Peptidyl 3-hydroxyproline binding properties of type I collagen suggest a function in fibril supramolecular assembly.

David M Hudson1, Lammy S Kim, MaryAnn Weis, Daniel H Cohn, David R Eyre.   

Abstract

Proline residues in collagens are extensively hydroxylated post-translationally. A rare form of this modification, (3S,2S)-l-hydroxyproline (3Hyp), remains without a clear function. Disruption of the enzyme complex responsible for prolyl 3-hydroxylation results in severe forms of recessive osteogenesis imperfecta (OI). These OI types exhibit a loss of or reduction in the level of 3-hydroxylation at two proline residues, α1(I) Pro986 and α2(I) Pro707. Whether the resulting brittle bone phenotype is caused by the lack of the 3-hydroxyl addition or by another function of the enzyme complex is unknown. We have speculated that the most efficient mechanism for explaining the chemistry of collagen intermolecular cross-linking is for pairs of collagen molecules in register to be the subunit that assembles into fibrils. In this concept, the exposed hydroxyls from 3Hyp are positioned within mutually interactive binding motifs on adjacent collagen molecules that contribute through hydrogen bonding to the process of fibril supramolecular assembly. Here we report observations on the physical binding properties of 3Hyp in collagen chains from experiments designed to explore the potential for interaction using synthetic collagen-like peptides containing 3Hyp. Evidence of self-association was observed between a synthetic peptide containing 3Hyp and the CB6 domain of the α1(I) chain, which contains the single fully 3-hydroxylated proline. Using collagen from a case of severe recessive OI with a CRTAP defect, in which Pro986 was minimally 3-hydroxylated, such binding was not observed. Further study of the role of 3Hyp in supramolecular assembly is warranted for understanding the evolution of tissue-specific variations in collagen fibril organization.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22380708      PMCID: PMC3314591          DOI: 10.1021/bi2019139

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  40 in total

Review 1.  Collagen polymorphism: its origins in the amino acid sequence.

Authors:  B B Doyle; D W Hukins; D J Hulmes; A Miller; J Woodhead-Galloway
Journal:  J Mol Biol       Date:  1975-01-05       Impact factor: 5.469

2.  The chemistry of the collagen cross-links. Purification and characterization of cross-linked polymeric peptide material from mature collagen containing unknown amino acids.

Authors:  N D Light; A J Bailey
Journal:  Biochem J       Date:  1980-02-01       Impact factor: 3.857

3.  Identification of a mutation causing deficient BMP1/mTLD proteolytic activity in autosomal recessive osteogenesis imperfecta.

Authors:  Víctor Martínez-Glez; Maria Valencia; José A Caparrós-Martín; Mona Aglan; Samia Temtamy; Jair Tenorio; Veronica Pulido; Uschi Lindert; Marianne Rohrbach; David Eyre; Cecilia Giunta; Pablo Lapunzina; Victor L Ruiz-Perez
Journal:  Hum Mutat       Date:  2011-11-30       Impact factor: 4.878

4.  The thermal transition of a non-hydroxylated form of collagen. Evidence for a role for hydroxyproline in stabilizing the triple-helix of collagen.

Authors:  R A Berg; D J Prockop
Journal:  Biochem Biophys Res Commun       Date:  1973-05-01       Impact factor: 3.575

5.  A hypothesis on the role of hydroxyproline in stabilizing collagen structure.

Authors:  G N Ramachandran; M Bansal; R S Bhatnagar
Journal:  Biochim Biophys Acta       Date:  1973-09-21

Review 6.  Cross-linking in collagen and elastin.

Authors:  D R Eyre; M A Paz; P M Gallop
Journal:  Annu Rev Biochem       Date:  1984       Impact factor: 23.643

7.  Synthesis and physical properties of (hydroxyproline-proline-glycine)10: hydroxyproline in the X-position decreases the melting temperature of the collagen triple helix.

Authors:  K Inouye; Y Kobayashi; Y Kyogoku; Y Kishida; S Sakakibara; D J Prockop
Journal:  Arch Biochem Biophys       Date:  1982-11       Impact factor: 4.013

8.  Staggered molecular packing in crystals of a collagen-like peptide with a single charged pair.

Authors:  R Z Kramer; M G Venugopal; J Bella; P Mayville; B Brodsky; H M Berman
Journal:  J Mol Biol       Date:  2000-09-01       Impact factor: 5.469

9.  Effects of the stereo-configuration of the hydroxyl group in 4-hydroxyproline on the triple-helical structures formed by homogenous peptides resembling collagen.

Authors:  K Inouye; S Sakakibara; D J Prockop
Journal:  Biochim Biophys Acta       Date:  1976-01-20

10.  Polymeric C-terminal cross-linked material from type-I collagen. A modified method for purification, anomalous behaviour on gel filtration, molecular weight estimation, carbohydrate content and lipid content.

Authors:  N D Light; A J Bailey
Journal:  Biochem J       Date:  1980-07-01       Impact factor: 3.857

View more
  12 in total

1.  Developmental Stage-dependent Regulation of Prolyl 3-Hydroxylation in Tendon Type I Collagen.

Authors:  Yuki Taga; Masashi Kusubata; Kiyoko Ogawa-Goto; Shunji Hattori
Journal:  J Biol Chem       Date:  2015-11-13       Impact factor: 5.157

2.  Molecular properties and fibril ultrastructure of types II and XI collagens in cartilage of mice expressing exclusively the α1(IIA) collagen isoform.

Authors:  Audrey McAlinden; Geoffrey Traeger; Uwe Hansen; Mary Ann Weis; Soumya Ravindran; Louisa Wirthlin; David R Eyre; Russell J Fernandes
Journal:  Matrix Biol       Date:  2013-10-07       Impact factor: 11.583

3.  P3h3-null and Sc65-null Mice Phenocopy the Collagen Lysine Under-hydroxylation and Cross-linking Abnormality of Ehlers-Danlos Syndrome Type VIA.

Authors:  David M Hudson; MaryAnn Weis; Jyoti Rai; Kyu Sang Joeng; Milena Dimori; Brendan H Lee; Roy Morello; David R Eyre
Journal:  J Biol Chem       Date:  2017-01-23       Impact factor: 5.157

Review 4.  Collagen prolyl 3-hydroxylation: a major role for a minor post-translational modification?

Authors:  David M Hudson; David R Eyre
Journal:  Connect Tissue Res       Date:  2013-06-21       Impact factor: 3.417

5.  Posttranslational modifications in type I collagen from different tissues extracted from wild type and prolyl 3-hydroxylase 1 null mice.

Authors:  Elena Pokidysheva; Keith D Zientek; Yoshihiro Ishikawa; Kazunori Mizuno; Janice A Vranka; Nathan T Montgomery; Douglas R Keene; Tatsuya Kawaguchi; Kenji Okuyama; Hans Peter Bächinger
Journal:  J Biol Chem       Date:  2013-07-16       Impact factor: 5.157

Review 6.  Bone collagen: new clues to its mineralization mechanism from recessive osteogenesis imperfecta.

Authors:  David R Eyre; Mary Ann Weis
Journal:  Calcif Tissue Int       Date:  2013-03-19       Impact factor: 4.333

7.  Substitution of murine type I collagen A1 3-hydroxylation site alters matrix structure but does not recapitulate osteogenesis imperfecta bone dysplasia.

Authors:  Wayne A Cabral; Nadja Fratzl-Zelman; MaryAnn Weis; Joseph E Perosky; Adrienne Alimasa; Rachel Harris; Heeseog Kang; Elena Makareeva; Aileen M Barnes; Paul Roschger; Sergey Leikin; Klaus Klaushofer; Antonella Forlino; Peter S Backlund; David R Eyre; Kenneth M Kozloff; Joan C Marini
Journal:  Matrix Biol       Date:  2020-02-26       Impact factor: 11.583

8.  The development of a mature collagen network in cartilage from human bone marrow stem cells in Transwell culture.

Authors:  Alan D Murdoch; Timothy E Hardingham; David R Eyre; Russell J Fernandes
Journal:  Matrix Biol       Date:  2015-10-30       Impact factor: 11.583

9.  Genome-wide analysis identifies differential promoter methylation of Leprel2, Foxf1, Mmp25, Igfbp6, and Peg12 in murine tendinopathy.

Authors:  Katie J Trella; Jun Li; Eleni Stylianou; Vincent M Wang; Jonathan M Frank; Jorge Galante; John D Sandy; Anna Plaas; Robert Wysocki
Journal:  J Orthop Res       Date:  2016-08-29       Impact factor: 3.494

10.  Evolutionary origins of C-terminal (GPP)n 3-hydroxyproline formation in vertebrate tendon collagen.

Authors:  David M Hudson; Rachel Werther; MaryAnn Weis; Jiann-Jiu Wu; David R Eyre
Journal:  PLoS One       Date:  2014-04-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.